• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用分子建模技术理解与血管紧张素Ⅱ1型(AT(1))拮抗剂的高血压作用相关的静电和空间要求。

Understanding electrostatic and steric requirements related to hypertensive action of AT(1) antagonists using molecular modeling techniques.

作者信息

da C Silva Danielle, Maltarollo Vinicius G, de Lima Emmanuela Ferreira, Weber Karen Cacilda, Honorio Kathia M

机构信息

Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André, Brazil.

出版信息

J Mol Model. 2014 Jul;20(7):2231. doi: 10.1007/s00894-014-2231-7. Epub 2014 Jun 17.

DOI:10.1007/s00894-014-2231-7
PMID:24935104
Abstract

AT1 receptor is an interesting biological target involved in several important diseases, such as blood hypertension and cardiovascular pathologies. In this study we investigated the main electrostatic and steric features of a series of AT1 antagonists related to hypertensive activity using structure and ligand-based strategies (docking and CoMFA). The generated 3D model had good internal and external consistency and was used to predict the potency of an external test set. The predicted values of pIC50 are in good agreement with the experimental results of biological activity, indicating that the 3D model can be used to predict the biological property of untested compounds. The electrostatic and steric CoMFA maps showed molecular recognition patterns, which were analyzed with structure-based molecular modeling studies (docking). The most and the least potent compounds docked into the AT1 binding site were subjected to molecular dynamics simulations with the aim to verify the stability and the flexibility of the ligand-receptor interactions. These results provided valuable insights on the electronic/structural requirements to design novel AT1 antagonists.

摘要

AT1受体是一个涉及多种重要疾病的有趣生物学靶点,如高血压和心血管疾病。在本研究中,我们使用基于结构和配体的策略(对接和比较分子场分析法)研究了一系列与高血压活性相关的AT1拮抗剂的主要静电和空间特征。生成的三维模型具有良好的内部和外部一致性,并用于预测外部测试集的效力。pIC50的预测值与生物活性的实验结果高度一致,表明该三维模型可用于预测未测试化合物的生物学性质。静电和空间比较分子场分析法图谱显示了分子识别模式,并通过基于结构的分子建模研究(对接)进行了分析。对接至AT1结合位点的活性最强和最弱的化合物进行了分子动力学模拟,以验证配体-受体相互作用的稳定性和灵活性。这些结果为设计新型AT1拮抗剂的电子/结构要求提供了有价值的见解。

相似文献

1
Understanding electrostatic and steric requirements related to hypertensive action of AT(1) antagonists using molecular modeling techniques.运用分子建模技术理解与血管紧张素Ⅱ1型(AT(1))拮抗剂的高血压作用相关的静电和空间要求。
J Mol Model. 2014 Jul;20(7):2231. doi: 10.1007/s00894-014-2231-7. Epub 2014 Jun 17.
2
Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPARg.针对双重靶向AT1和PPARg的咪唑并吡啶衍生物的分子对接、三维定量构效关系及结构优化
Oncotarget. 2017 Apr 11;8(15):25612-25627. doi: 10.18632/oncotarget.15778.
3
Homology modeling, binding site identification and docking study of human angiotensin II type I (Ang II-AT1) receptor.同源建模、人血管紧张素 II 型 1 型受体 (Ang II-AT1) 结合位点鉴定及对接研究。
Biomed Pharmacother. 2015 Aug;74:42-8. doi: 10.1016/j.biopha.2015.07.008. Epub 2015 Jul 31.
4
CoMFA and CoMSIA studies of angiotensin (AT1) receptor antagonists.血管紧张素(AT1)受体拮抗剂的比较分子力场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)研究
J Mol Model. 2002 Oct;8(10):290-301. doi: 10.1007/s00894-002-0097-6. Epub 2002 Oct 2.
5
Development of CoMFA models of affinity and selectivity to angiotensin II type-1 and type-2 receptors.针对血管紧张素II 1型和2型受体的亲和力和选择性的比较分子场分析(CoMFA)模型的开发。
J Mol Graph Model. 2007 Jul;26(1):145-53. doi: 10.1016/j.jmgm.2006.10.004. Epub 2006 Oct 26.
6
Identifying structural features related to the biological activity of a series of AT1 antagonists from fragment-based drug design.从基于片段的药物设计中识别与一系列血管紧张素Ⅱ1型受体拮抗剂生物活性相关的结构特征。
Protein Pept Lett. 2014 Jun;21(6):542-9. doi: 10.2174/092986652106140425122007.
7
Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.通过分子模拟研究发现具有强效降压作用的取代咪唑基联苯磺酰脲类血管紧张素 II AT1 受体拮抗剂配体。
Interdiscip Sci. 2015 Sep;7(3):221-32. doi: 10.1007/s12539-015-0006-1. Epub 2015 Jul 19.
8
Molecular modeling, quantum polarized ligand docking and structure-based 3D-QSAR analysis of the imidazole series as dual AT(1) and ET(A) receptor antagonists.咪唑类双重 AT1 和 ET(A)受体拮抗剂的分子建模、量子极化配体对接和基于结构的 3D-QSAR 分析。
Acta Pharmacol Sin. 2013 Dec;34(12):1592-606. doi: 10.1038/aps.2013.129.
9
Multiple templates-based homology modeling enhances structure quality of AT1 receptor: validation by molecular dynamics and antagonist docking.基于多种模板的同源建模提高 AT1 受体结构质量:分子动力学和拮抗剂对接验证。
J Mol Model. 2011 Jul;17(7):1565-77. doi: 10.1007/s00894-010-0860-z. Epub 2010 Oct 6.
10
Structure-based design of hERG-neutral antihypertensive oxazalone and imidazolone derivatives.基于结构的设计新型 hERG 中性抗高血压恶唑酮和咪唑烷酮衍生物。
J Mol Graph Model. 2018 Jan;79:103-117. doi: 10.1016/j.jmgm.2017.10.011. Epub 2017 Oct 18.

引用本文的文献

1
Rational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptors.针对血管紧张素 II 1型和2型受体的分子的合理药物设计与合成。
Molecules. 2015 Mar 2;20(3):3868-97. doi: 10.3390/molecules20033868.

本文引用的文献

1
Molecular features related to HIV integrase inhibition obtained from structure- and ligand-based approaches.从基于结构和配体的方法中获得的与HIV整合酶抑制相关的分子特征。
PLoS One. 2014 Jan 8;9(1):e81301. doi: 10.1371/journal.pone.0081301. eCollection 2014.
2
Intracardiac intracellular angiotensin system in diabetes.心脏细胞内肾素-血管紧张素系统与糖尿病
Am J Physiol Regul Integr Comp Physiol. 2012 Mar 1;302(5):R510-7. doi: 10.1152/ajpregu.00512.2011. Epub 2011 Dec 14.
3
Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.
比较分子场分析(CoMFA)。1. 形状对类固醇与载体蛋白结合的影响。
J Am Chem Soc. 1988 Aug 1;110(18):5959-67. doi: 10.1021/ja00226a005.
4
New insights into angiotensin receptor actions: from blood pressure to aging.血管紧张素受体作用的新见解:从血压到衰老。
Curr Opin Nephrol Hypertens. 2011 Jan;20(1):84-8. doi: 10.1097/MNH.0b013e3283414d40.
5
Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.阻断大脑血管紧张素 II AT1 受体可改善应激、焦虑、脑炎症和缺血:治疗意义。
Psychoneuroendocrinology. 2011 Jan;36(1):1-18. doi: 10.1016/j.psyneuen.2010.10.001. Epub 2010 Oct 29.
6
Multiple templates-based homology modeling enhances structure quality of AT1 receptor: validation by molecular dynamics and antagonist docking.基于多种模板的同源建模提高 AT1 受体结构质量:分子动力学和拮抗剂对接验证。
J Mol Model. 2011 Jul;17(7):1565-77. doi: 10.1007/s00894-010-0860-z. Epub 2010 Oct 6.
7
Insights into the molecular requirements for the anti-obesity activity of a series of CB1 ligands.揭示一系列 CB1 配体抗肥胖活性的分子需求。
Chem Biol Drug Des. 2010 Oct;76(4):320-9. doi: 10.1111/j.1747-0285.2010.01016.x. Epub 2010 Sep 2.
8
Artificial neural networks and the study of the psychoactivity of cannabinoid compounds.人工神经网络与大麻素化合物精神活性的研究。
Chem Biol Drug Des. 2010 Jun;75(6):632-40. doi: 10.1111/j.1747-0285.2010.00966.x.
9
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.血管紧张素转换酶与心血管疾病的药物研发。
Drug Discov Today. 2010 May;15(9-10):332-41. doi: 10.1016/j.drudis.2010.02.003. Epub 2010 Feb 17.
10
Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands.基于药效团的高亲和力 5-HT1A 受体配体的 3D QSAR 研究。
Eur J Med Chem. 2010 Apr;45(4):1508-14. doi: 10.1016/j.ejmech.2009.12.059. Epub 2010 Jan 13.